Immediate Impact
1 from Science/Nature 54 standout
Citing Papers
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
2025 Standout
Advanced disease therapeutics using engineered living drug delivery systems
2025 Standout
Works of Gaia Gallo being referenced
Long-term efficacy and safety of ixekizumab: A 5-year analysis of the UNCOVER-3 randomized controlled trial
2020
Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Gaia Gallo | 882 | 442 | 438 | 80 | 1.2k | |
| Luke Peterson | 917 | 456 | 450 | 59 | 1.2k | |
| Alessandro Giunta | 750 | 417 | 244 | 77 | 1.3k | |
| Marta Ferrán | 906 | 626 | 259 | 79 | 1.4k | |
| Ian Landells | 723 | 563 | 180 | 38 | 1.2k | |
| Giacomo Caldarola | 619 | 553 | 294 | 87 | 1.1k | |
| A Nyfors | 431 | 270 | 259 | 54 | 1.1k | |
| Ana P. Lacerda | 411 | 130 | 442 | 66 | 1.4k | |
| Amy M. DeLozier | 353 | 825 | 850 | 51 | 1.7k | |
| D.E. Furst | 411 | 399 | 536 | 47 | 1.6k | |
| Gloria C. Higgins | 376 | 129 | 535 | 52 | 1.7k |
All Works
Loading papers...